Author of the article: GlobeNewswire
Publishing date: Apr 27, 2021  â¢Â 51 minutes ago  â¢Â 4 minute read  â¢Â
Article content
Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND submission to the Chinese National Medical Products Administration (NMPA)
MIRAMAR, Fla., April 27, 2021 (GLOBE NEWSWIRE) â Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that in connection with its partnership with the National Institute for Viral Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing Youfeng International Consulting Co., Ltd and Beijing Guoxin Haixiang Equity Investment Partnership, the company has received a $2 million development payment from Beijing Youfeng Biological Technology, Ltd (Youfeng-BI). In exchange for this payment, Generex will provide
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development .
Generex Biotechnology Corp.December 31, 2020 GMT
The trademark application can be found at USPTO.gov by searching “Complete Vaccine” in the Trademark Electronic Search System (TESS)
Ii-Key-SARS-CoV-2 vaccine enters GMP production for clinical supply
Ii-Key epitopes selected that elicit both CD4+ T Helper cell (Th1) and CD8+ responses that are necessary for long-term immune memory
Ii-Key epitopes elicited no Th2 T cell responses that have been linked to antibody dependent enhancement of disease and cytokine storm
Home / Top News / Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
The trademark application can be found at USPTO.gov by searching “Complete Vaccine” in the Trademark Electronic Search System (TESS)
Ii-Key-SARS-CoV-2 vaccine enters GMP production for clinical supply
Ii-Key epitopes selected that elicit both CD4+ T Helper cell (Th1) and CD8+ responses that are necessary for long-term immune memory
Ii-Key epitopes elicited no Th2 T cell responses that have been linked to antibody dependent enhancement of disease and cytokine storm
TMCnet News
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
[December 31, 2020]
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
The trademark application can be found at USPTO.gov by searching âComplete Vaccineâ in the Trademark Electronic Search System (TESS)
Ii-Key-SARS-CoV-2 vaccine enters GMP production for clinical supply
Ii-Key epitopes selected that elicit both CD4+ T Helper cell (Th1) and CD8+ responses that are necessary for long-term immune memory
Ii-Key epitopes elicited no Th2 T cell responses that have been linked to antibody dependent enhancement of disease and cytokine storm
elsewhere in the country it s the city s 1st women led protest march comes after the country s prime minister. abdullah resigned. a multiple prime minister joseph moscato as announce that he will resign next month when his labor party has chosen a new leader calls for him to step down have been growing as the investigation into the murder of a prominent journalist gathers pace. was investigating alleged government corruption when she was killed in 2017 mr moscato the same as being too close to people being questioned by police a prominent businessman with alleged ties to government ministers has now been charged. in the coming period we will initiate a process so that our country will have a new prime minister. responding to mass protests calling for his immediate resignation multis beleaguered prime minister joseph muscat said he intends to resign but not until the 12th of january. nearly $20000.00 people around